← Browse by Condition
Medical Condition

relapsed refractory marginal zone lymphoma r r mzl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06149286 Phase 3
Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Enrollment
470 pts
Location
United States, Austr...
Sponsor
Regeneron Pharmaceuticals
View Trial →